Comparable Efficacy and Safety of Teriflunomide versus Dimethyl Fumarate for the Treatment of Relapsing-Remitting Multiple Sclerosis

BACKGROUND: The aim of this observational study is to investigate the efficacy and safety of two approved oral disease-modifying therapies (DMTs) in patients with remitting-relapsing multiple sclerosis (RRMS): dimethyl fumarate (DMF) vs. teriflunomide (TRF). METHODS: A total of 159 RRMS patients (82...

Descripción completa

Detalles Bibliográficos
Autores principales: Nehzat, Nasim, Mirmosayyeb, Omid, Barzegar, Mahdi, Vosoughi, Reza, Fazeli, Erfane, Shaygannejad, Vahid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298169/
https://www.ncbi.nlm.nih.gov/pubmed/34336283
http://dx.doi.org/10.1155/2021/6679197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298169/
https://www.ncbi.nlm.nih.gov/pubmed/34336283
http://dx.doi.org/10.1155/2021/6679197

Ejemplares similares